Myosin IIA-mediated forces regulate multicellular integrity during vascular sprouting.


Journal

Molecular biology of the cell
ISSN: 1939-4586
Titre abrégé: Mol Biol Cell
Pays: United States
ID NLM: 9201390

Informations de publication

Date de publication:
22 07 2019
Historique:
pubmed: 19 7 2019
medline: 10 1 2020
entrez: 19 7 2019
Statut: ppublish

Résumé

Angiogenic sprouting is a critical process involved in vascular network formation within tissues. During sprouting, tip cells and ensuing stalk cells migrate collectively into the extracellular matrix while preserving cell-cell junctions, forming patent structures that support blood flow. Although several signaling pathways have been identified as controlling sprouting, it remains unclear to what extent this process is mechanoregulated. To address this question, we investigated the role of cellular contractility in sprout morphogenesis, using a biomimetic model of angiogenesis. Three-dimensional maps of mechanical deformations generated by sprouts revealed that mainly leader cells, not stalk cells, exert contractile forces on the surrounding matrix. Surprisingly, inhibiting cellular contractility with blebbistatin did not affect the extent of cellular invasion but resulted in cell-cell dissociation primarily between tip and stalk cells. Closer examination of cell-cell junctions revealed that blebbistatin impaired adherens-junction organization, particularly between tip and stalk cells. Using CRISPR/Cas9-mediated gene editing, we further identified NMIIA as the major isoform responsible for regulating multicellularity and cell contractility during sprouting. Together, these studies reveal a critical role for NMIIA-mediated contractile forces in maintaining multicellularity during sprouting and highlight the central role of forces in regulating cell-cell adhesions during collective motility.

Identifiants

pubmed: 31318321
doi: 10.1091/mbc.E19-02-0076
pmc: PMC6727772
doi:

Substances chimiques

Protein Isoforms 0
Nonmuscle Myosin Type IIA EC 3.6.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1974-1984

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB000262
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL115553
Pays : United States

Références

Nat Commun. 2014 Nov 11;5:5343
pubmed: 25385672
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9944-9
pubmed: 20463286
BMC Cell Biol. 2006 Mar 01;7:12
pubmed: 16509970
Integr Biol (Camb). 2011 Jun;3(6):663-74
pubmed: 21445393
FASEB J. 2015 Nov;29(11):4555-67
pubmed: 26195589
PLoS One. 2015 Feb 06;10(2):e0117970
pubmed: 25658915
Exp Cell Res. 2014 Aug 15;326(2):295-306
pubmed: 24768700
Mol Biol Cell. 2003 Dec;14(12):4745-57
pubmed: 12960430
FASEB J. 2013 Apr;27(4):1351-61
pubmed: 23254340
Mol Biol Cell. 2005 Oct;16(10):4531-42
pubmed: 16030252
J Cell Biol. 2012 Apr 30;197(3):439-55
pubmed: 22547408
J Cell Biol. 2003 Jun 23;161(6):1163-77
pubmed: 12810700
PLoS One. 2012;7(3):e33476
pubmed: 22479403
J Cell Biol. 2016 Jan 18;212(2):143-55
pubmed: 26783298
PLoS One. 2015 Jul 23;10(7):e0133880
pubmed: 26204526
Integr Biol (Camb). 2012 Apr;4(4):431-9
pubmed: 22281872
J Cell Biol. 1992 Sep;118(6):1511-22
pubmed: 1522121
Int J Dev Biol. 2011;55(3):261-8
pubmed: 21710434
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1506-11
pubmed: 22307605
Dev Cell. 2008 Apr;14(4):570-81
pubmed: 18410732
Nat Rev Mol Cell Biol. 2009 Jul;10(7):445-57
pubmed: 19546857
Angiogenesis. 2012 Jun;15(2):253-64
pubmed: 22382584
J Cell Biol. 2012 Mar 5;196(5):641-52
pubmed: 22391038
Cell Mol Bioeng. 2010 Mar 1;3(1):68-75
pubmed: 21116436
J Cell Biol. 2018 Aug 6;217(8):2813-2830
pubmed: 29858212
Lab Chip. 2011 Jul 7;11(13):2175-81
pubmed: 21617793
Sci Rep. 2015 Jul 13;5:11458
pubmed: 26165921
Nat Cell Biol. 2010 Jul;12(7):696-702
pubmed: 20543839
Nat Rev Clin Oncol. 2009 Jun;6(6):315-26
pubmed: 19483738
Nat Cell Biol. 2014 Apr;16(4):309-21
pubmed: 24658686
Dev Biol. 2015 Jan 1;397(1):103-15
pubmed: 25446029
Sci Rep. 2016 Feb 23;6:21362
pubmed: 26903154
Annu Rev Cell Dev Biol. 2010;26:315-33
pubmed: 19575647
J Cell Sci. 1994 Dec;107 ( Pt 12):3655-63
pubmed: 7706414
Exp Cell Res. 2007 Oct 1;313(16):3616-23
pubmed: 17673200
Nat Methods. 2010 Dec;7(12):969-71
pubmed: 21076420
Curr Biol. 2009 Feb 10;19(3):260-5
pubmed: 19185493
Curr Biol. 2009 Apr 28;19(8):668-74
pubmed: 19345098
Dev Cell. 2012 Jan 17;22(1):158-71
pubmed: 22209329
Bioarchitecture. 2012 Nov-Dec;2(6):220-7
pubmed: 23267416
J Cell Sci. 2000 Apr;113 ( Pt 7):1287-98
pubmed: 10704379
Am J Physiol Cell Physiol. 2009 Jul;297(1):C179-87
pubmed: 19439531
J Cell Biol. 2012 Oct 29;199(3):545-63
pubmed: 23091067
J Cell Biol. 2009 Feb 23;184(4):481-90
pubmed: 19221195
Converg Sci Phys Oncol. 2017;3:
pubmed: 29531793
Cell. 2006 Jun 30;125(7):1361-74
pubmed: 16814721
Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):8758-8763
pubmed: 28765370
J Cell Sci. 1999 Oct;112 ( Pt 19):3249-58
pubmed: 10504330
Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):133-138
pubmed: 29255056
Cell. 2009 Jun 12;137(6):1124-35
pubmed: 19524514
Physiol Rev. 2006 Jan;86(1):279-367
pubmed: 16371600
Mol Biol Cell. 2004 Mar;15(3):982-9
pubmed: 14699073
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6712-7
pubmed: 23569284
Proc Natl Acad Sci U S A. 1995 May 23;92(11):5067-71
pubmed: 7761449
Microvasc Res. 2004 Jan;67(1):64-77
pubmed: 14709404
Biol Open. 2013 Feb 06;2(4):368-72
pubmed: 23616920
Nature. 2016 Jan 21;529(7586):316-25
pubmed: 26791722
Biophys J. 2010 Apr 21;98(8):L29-31
pubmed: 20409454
Nat Cell Biol. 2016 Dec;18(12):1311-1323
pubmed: 27842057
Blood. 2012 Oct 18;120(16):3371-81
pubmed: 22936663
Nat Commun. 2017 Dec 20;8(1):2210
pubmed: 29263363
Nature. 2007 Feb 15;445(7129):776-80
pubmed: 17259973
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):492-497
pubmed: 28034921
J Biomech. 2016 May 24;49(8):1340-1346
pubmed: 26556715
Nat Commun. 2017 Aug 29;8(1):371
pubmed: 28851858
Nat Rev Mol Cell Biol. 2007 Jun;8(6):464-78
pubmed: 17522591
Biointerphases. 2013 Dec;8(1):32
pubmed: 24706149
Exp Cell Res. 2016 Sep 10;347(1):161-70
pubmed: 27498166
Sci Rep. 2019 Jan 9;9(1):12
pubmed: 30626885

Auteurs

Christine Yoon (C)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Colin Choi (C)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Sarah Stapleton (S)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Teodelinda Mirabella (T)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Caroline Howes (C)

Department of Mechanical, Aerospace and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180.

Li Dong (L)

Department of Mechanical, Aerospace and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180.
The Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX 78712.

Jessica King (J)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Jinling Yang (J)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.

Assad Oberai (A)

Department of Mechanical, Aerospace and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180.
Department of Aerospace and Mechanical Engineering, University of Southern California, Los Angeles, CA 90007.

Jeroen Eyckmans (J)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Christopher S Chen (CS)

Biological Design Center, Department of Biomedical Engineering, Boston University, Boston, MA 02215.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH